Eric H. Sasso - Concepedia

Author

Eric H. Sasso

ScienceSouth ORCID

Also Known As

D. Khanna, Doruk Erkan, E H Sasso, E Sasso, E. H. SASSO, E. H. Sasso, E. Sasso, E.H. Sasso, ERIC H. SASSO, Eric H Sasso

102

Publications

Citations

H-Index

Concepts

All Affiliations

ScienceSouth University of Washington Virginia Mason Medical Center Leiden University Medical Center Abbott Fund

About

Eric H. Sasso is an author at ScienceSouth specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.2K
2	Natural Sciences	2	2	322
3	Public Health	2	2	113
4	Allergy	1	1	125
5	Cell Biology	1	1	15

Eric H. Sasso

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor Zehra Kaymakcalan, Paul Sakorafas, Sahana Bose, Clinical Immunology InflammationComplement SystemAnti-inflammatoryAutoimmune DiseaseImmunology	2009	309
Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial Dafna D. Gladman, Philip J. Mease, Christopher T. Ritchlin, Arthritis & Rheumatism	2007	296
Human IgA and IgG F(ab’)2 that bind to staphylococcal protein A belong to the VHIII subgroup Eric H. Sasso, GJ Silverman, Mart Mannik The Journal of Immunology	1991	213
Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. Eric H. Sasso, Gregg J. Silverman, Mart Mannik The Journal of Immunology Spa BindingProtein AssemblyBacteriologyMolecular BiologyProtein Folding	1989	197
Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy. Mark C. Genovese, Philip J. Mease, G. T. D. Thomson, PubMed	2007	190
Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL Kenneth B. Gordon, Kim Papp, Yves Poulin, Journal of the American Academy of Dermatology Open-label Extension StudyLong-term EfficacyMedicineSevere PsoriasisClinical Dermatology	2011	173
The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. Jan Hillson, N S Karr, I R Oppliger, The Journal of Experimental Medicine Protein AssemblyImmunologyMolecular BiologyImmunodominanceAntigen Processing	1993	125
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial Dafna D. Gladman, Philip J. Mease, M. Cifaldi, Annals of the Rheumatic Diseases	2006	125
Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT Dafna D. Gladman, Philip J. Mease, Ernest Choy, Arthritis Research & Therapy	2010	102
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial Karen Hambardzumyan, Rebecca Bolce, Saedís Saevarsdóttir, Annals of the Rheumatic Diseases	2014	98

Page 1